To further test this hypothesis, we first knocked down StarD13 in three different ovarian cancer cell lines: SKOV-3 (Supplemental Fig. S1A), Caov-3 (Supplemental Fig. SIB) and PA-1 (Supplemental Fig. SIC) then examined the impact of this knock down on cell proliferation. The gene discussed is STARD13; the disease is ovarian carcinoma.